A detailed history of Janus Henderson Group PLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 156,264 shares of AMPH stock, worth $7.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
156,264
Previous 159,198 1.84%
Holding current value
$7.83 Million
Previous $6.99 Million 10.59%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$38.65 - $43.48 $113,399 - $127,570
-2,934 Reduced 1.84%
156,264 $6.25 Million
Q1 2024

May 15, 2024

SELL
$42.85 - $63.45 $257,100 - $380,700
-6,000 Reduced 3.63%
159,198 $6.99 Million
Q4 2023

Feb 14, 2024

BUY
$44.49 - $62.93 $2.34 Million - $3.31 Million
52,618 Added 46.74%
165,198 $10.2 Million
Q3 2023

Nov 14, 2023

BUY
$45.51 - $65.0 $705,632 - $1.01 Million
15,505 Added 15.97%
112,580 $5.18 Million
Q2 2023

Aug 14, 2023

SELL
$35.77 - $58.38 $245,596 - $400,837
-6,866 Reduced 6.61%
97,075 $5.58 Million
Q1 2023

May 15, 2023

BUY
$27.99 - $37.92 $2.69 Million - $3.65 Million
96,226 Added 1247.26%
103,941 $3.9 Million
Q4 2022

Feb 14, 2023

BUY
$27.93 - $31.27 $215,479 - $241,248
7,715 New
7,715 $216,000
Q3 2022

Nov 14, 2022

SELL
$27.56 - $37.75 $1,433 - $1,963
-52 Reduced 0.67%
7,715 $217,000
Q2 2022

Aug 15, 2022

SELL
$29.79 - $42.29 $10.6 Million - $15 Million
-355,737 Reduced 97.86%
7,767 $270,000
Q1 2022

May 16, 2022

SELL
$22.96 - $36.45 $14 Million - $22.2 Million
-609,689 Reduced 62.65%
363,504 $13 Million
Q4 2021

Feb 14, 2022

BUY
$18.14 - $23.29 $47,925 - $61,532
2,642 Added 0.27%
973,193 $22.7 Million
Q3 2021

Nov 16, 2021

BUY
$17.83 - $21.49 $7.41 Million - $8.93 Million
415,515 Added 74.86%
970,551 $18.5 Million
Q2 2021

Aug 16, 2021

BUY
$17.11 - $20.92 $9.5 Million - $11.6 Million
555,036 New
555,036 $11.2 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.46B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.